ARCA biopharma Announces First Patients Enrolled in ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 (AB201) as a Potential Treatment for COVID-19 Posted on December 15, 2020 by ARCA IT - Press Release, Uncategorized 12.15-rNAPc2-FPE-ASPEN-COVID-Trial
ARCA biopharma Announces Location Change for 2020 Annual Meeting of Stockholders Posted on December 9, 2020 by ARCA IT - Press Release, Uncategorized 12.9-ARCA-Annual-Meeting-Location-Change-FINAL